Table 1.
| Na channel | CBZ |
| FBM | |
| LAC | |
| LTG | |
| OXC | |
| PHT | |
| RUF | |
| TPM | |
| VPA | |
| ZNS | |
| Ca channel | ESX (low voltage T-type) |
| GBP (high voltage) | |
| LTG (high voltage N-type) | |
| OXC | |
| PGB (high voltage) | |
| PB | |
| PHT | |
| TPM (high voltage L-type) | |
| VPA (low voltage T-type) | |
| ZNS (high voltage T-type) | |
| GABA enhancers | Benzodiazepines |
| PB | |
| CBZ | |
| GBP | |
| PGB | |
| TGB (GABA uptake inhibitor) | |
| TPM | |
| VIG (GABA transaminase inhibitor) | |
| VPA | |
| Glutamate antagonists | CBZ |
| FBM | |
| OXC | |
| PB | |
| TPM | |
| Carbonic anhydrase inhibitors | TPM |
| ZNS | |
| Other | CBZ (adenosine receptor binding) |
| LAC (collapsin responsive mediator protein-2) | |
| LEV (synaptic protein SV2A binding) | |
| PHT (inhibit neurotransmitter release) |
Abbreviations: CBZ: carbamazepine; ESX: ethosuximide; FBM: felbamate; GBP: gabapentin; LEV: levetiracetam; LTG: lamotrigine; OXC: oxcarbazepine; PB: Phenobarbital; PHT: phenytoin; RUF: rufinamide; TGB: tiagabine; TPM: topiramate; VIG: vigabatrin; VPA: valproic acid.